These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 7297498)

  • 1. Recombination of fragments of human growth hormone: altered activity profile of the recombinant molecule.
    Reagan CR; Kostyo JL; Mills JB; Gennick SE; Messina JL; Wagner SA; Wilhelmi AE
    Endocrinology; 1981 Nov; 109(5):1663-71. PubMed ID: 7297498
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthetic fragment of human growth hormone with hyperglycemic properties: residues 44-77.
    Lostroh AJ; Krahl ME
    Diabetes; 1978 May; 27(5):597-8. PubMed ID: 648751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hybrid noncovalent complex of fragments of porcine and human growth hormones with diabetogenic activity.
    Gennick SE; Kostyo JL; Mills JB; Eden S
    Endocrinology; 1983 Jun; 112(6):2069-75. PubMed ID: 6303758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragments of human growth hormone produced by digestion with thrombin: chemistry and biological properties.
    Mills JB; Kostyo JL; Reagan CR; Wagner SA; Moseley MH; Wilhelmi AE
    Endocrinology; 1980 Aug; 107(2):391-9. PubMed ID: 7389660
    [No Abstract]   [Full Text] [Related]  

  • 5. Two contiguous thrombin fragments of human somatotropin form a functionally active recombinant, but the two homologous fragments from sheep hormone do not.
    Gráf L; Li CH; Cheng CH; Jibson MD
    Biochemistry; 1981 Dec; 20(25):7251-8. PubMed ID: 6274394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human somatotropin. Noncovalent interaction of two thrombin fragments restores receptor-binding activity.
    Gràf L; Cheng CH; Li CH
    Int J Pept Protein Res; 1981 Oct; 18(4):409-12. PubMed ID: 6273350
    [No Abstract]   [Full Text] [Related]  

  • 7. Human somatotropin 61. A simple method to predict potential of somatotropin fragments for noncovalent recombination by radioreceptor assay.
    Cheng CH; Gráf L; Li CH
    Int J Pept Protein Res; 1982 Mar; 19(3):240-2. PubMed ID: 6288585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragments of human growth hormone produced by digestion with bromelain. Chemistry and biological properties.
    Mills JB; Gennick SE; Kostyo JL
    Biochim Biophys Acta; 1983 Jan; 742(1):169-74. PubMed ID: 6297585
    [No Abstract]   [Full Text] [Related]  

  • 9. A hyperglycemic peptide from pituitary growth hormone: preparation with pepsin and assay in ob-ob mice.
    Lostroh AJ; Krahl ME
    Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1244-6. PubMed ID: 4598296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diabetogenic activity of fragments of human growth hormone in obese (ob/ob) mice.
    Reagan CR
    Diabetes; 1978 Sep; 27(9):883-8. PubMed ID: 150989
    [No Abstract]   [Full Text] [Related]  

  • 11. Human growth hormone fragments 1-43 and 44-191: in vitro somatogenic activity and receptor binding characteristics in human and nonprimate systems.
    Rowlinson SW; Waters MJ; Lewis UJ; Barnard R
    Endocrinology; 1996 Jan; 137(1):90-5. PubMed ID: 8536647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementation of human growth hormone (GH) peptide 1-134 with C-terminal fragments of human GH produced by digestion with bromelain.
    Thorson JA; Sauder SE; Gennick SE; Kostyo JL; Mills JB
    Endocrinology; 1983 Mar; 112(3):782-7. PubMed ID: 6822209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human somatotropin. 55. Synthesis and growth-promoting activity of peptide analogs of the carboxyl terminal plasmin fragment.
    Blake J; Li CH
    Int J Pept Protein Res; 1978 May; 11(5):315-22. PubMed ID: 681075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that the N-terminus of human growth hormone is involved in expression of its growth promoting, diabetogenic, and insulin-like activities.
    Towns R; Kostyo JL; Vogel T; Sakal E; Tchelet A; Maher R; Gertler A
    Endocrinology; 1992 Mar; 130(3):1225-30. PubMed ID: 1537288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a putative GH-releasing factor (GRF) batch as predominantly ovine CRF with a small quantity of human GRF.
    Tannenbaum GS; van der Rest M; Downs TR; Frohman LA
    Endocrinology; 1986 Mar; 118(3):1246-8. PubMed ID: 3081327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of human growth hormone from pre-extracted pituitary residues.
    Mecklenburg RS; Barrett RJ
    J Clin Endocrinol Metab; 1969 Mar; 29(3):412-6. PubMed ID: 5773077
    [No Abstract]   [Full Text] [Related]  

  • 17. Purification and characterization of recombinant mouse growth hormone binding protein produced in the baculovirus expression system.
    Thordarson G; Wu K; Talamantes F
    Protein Expr Purif; 1996 Feb; 7(1):74-80. PubMed ID: 9172786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of constrained peptide analogues related to the N-terminal region of human growth hormone.
    Ede NJ; Lim N; Rae ID; Ng FM; Hearn MT
    Pept Res; 1991; 4(3):171-6. PubMed ID: 1823187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slow metabolic clearance rate of the 20,000-dalton variant of human growth hormone: implications for biological activity.
    Baumann G; Stolar MW; Buchanan TA
    Endocrinology; 1985 Oct; 117(4):1309-13. PubMed ID: 4029078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased sensitivity of adipose tissue to insulin after in vivo treatment of yellow Avy/A obese mice with amino-terminal peptides of human growth hormone.
    Frigeri LG; Teguh C; Ling N; Wolff GL; Lewis UJ
    Endocrinology; 1988 Jun; 122(6):2940-5. PubMed ID: 3131129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.